Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 32 results in range #1 to #32.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Bibliography (from DOI: 10.1038/s41392-020-0110-5): Title, Statement: P94, Statement: P108, Statement: P108243, Sitelink
  2. Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5): Title
  3. Competing interests (from DOI: 10.1038/s41392-020-0110-5): Title
  4. Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5): Title
  5. Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5): Title
  6. Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5): Title
  7. Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5): Title
  8. Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5): Title
  9. Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  10. Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  11. Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  12. Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  13. Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  14. Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  15. Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  16. Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  17. Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  18. Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  19. Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  20. Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  21. Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5): Title
  22. Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  23. Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  24. Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  25. Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  26. Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  27. Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  28. Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  29. Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  30. Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  31. Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  32. Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:EntityUsage/Q10035"